Agilent Posts Double-Digit Falloff in Q4 Revenues, Delays Varian Deal to 2010

Agilent reported a 9 percent slide in its Bio-Analytical Measurement segment amid a 21 percent drop in overall revenues for its fiscal fourth quarter, and said that its planned $1.5 billion acquisition of Varian is now expected to close in early 2010 instead of the end of 2009 as previously planned.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories